Sign In
Sign Out
My Account
Subscribe
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
Special reports
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 2, 2000
View Archived Issues
InSite Vision licenses novel TIGR modifier gene
Read More
Nexell acquires access to Diaclone antibodies for use in cell therapy
Read More
Patent applications filed by IGT for neuropharmaceuticals
Read More
Inhale Therapeutic Systems makes considerable progress in 1999
Read More
Allergan highlights Q4 1999 progress
Read More
Promising Sepracor compound with triple mechanism of action enters clinical testing
Read More
Cel-Sci receives MIPS award to support TB vaccine development
Read More
Phase II testing of third-generation ultrasound contrast agent commences at Acusphere
Read More
Ares-Serono licenses rhLIF from Amrad for infertility indication
Read More
Brief application of PEG reverses damage from spinal cord injury in guinea pigs
Read More
Are cannabinoid receptors involved in the IOP-lowering effects of cannabinoids?
Read More
Monsanto and Pharmacia & Upjohn file preliminary joint proxy statement with SEC
Read More
1F7 antibody inhibits destruction of CD4+ cells
Read More
Diabetes vaccine from Diamyd completes phase I testing
Read More
Patient enrollment completed in phase II trial of memantine for AIDS-related dementia
Read More
Patient enrollment begins in U.S. phase III trial of beraprost
Read More
NDA filed for once-daily didanosine capsules
Read More
Diacyl hydrazine compounds from SB target cathepsin K
Read More
Isis compounds modulate expression of antiapoptotic proteins A1 and mcl-1
Read More
More substituted carbapenems designed at Merck for infections due to resistant pathogens
Read More
Improved anticancer anthracene derivatives designed at BTG
Read More
Visudyne market introduction announced
Read More
Piperidine, pyrrolidine and pyrroline derivatives selectively affect 5-HT function
Read More
Contrast agents for radiological use in development at Guerbet
Read More
Synthesis of TA-949, an orally active 1-beta-methylcarbapenem
Read More
Apoptotic and antibacterial cyclohexapeptide fungal metabolite discovered in Japan
Read More
Edex/Viridal preferred, more efficacious than other ED therapies
Read More
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe